人物經歷
教育經歷
2011年09月-2014年06月 中國農業科學院研究生院預防獸醫學 博士
2004年09月-2007年06月 西北民族大學 臨床獸醫學 碩士
1998年09月-2002年07月 西北民族學院 動物醫學 學士
工作經歷
2002年07月以來,在西北民族大學從事教學科研工作。
研究方向
病原生物學與基因工程
主要成就
主要學術論文
(1)Ruofei Feng(通訊作者).Encephalomyocarditis VirusStructural Protein VP3 Interacts with MAVS and Promotes its AutophagicDegradation to Interfere with the Type I Interferon Signaling Pathway. FrontBiosci (Landmark Ed). 2024 Jul 25;29(7):273. doi: 10.31083/j.fbl2907273.
(2)Ruofei Feng(通訊作者).The complex interplaybetween encephalomyocarditis virus and the host defence system. Virulence. 2024Dec;15(1):2383559. doi: 10.1080/21505594.2024.2383559.
(3)Ruofei Feng(通訊作者).Pseudorabies virus VHSprotein abrogates interferon responses by blocking NF-κB and IRF3 nucleartranslocation. Virol Sin. 2024 May 30:S1995-820X(24)00078-6. doi:10.1016/j.virs.2024.05.009.
(4) Ruofei Feng(通訊作者). Mammalian orthoreoviruscapsid protein σ3 antagonizes RLR-mediated antiviral responses by degradingMAVS. mSphere. 2024 Jun 25;9(6):e0023624. doi: 10.1128/msphere.00236-24. Epub2024 May 17.
(5)Ruofei Feng(通訊作者).Pseudorabies virus UL38attenuates the cGAS-STING signaling pathway by recruiting Tollip to promoteSTING for autophagy degradation. Virol J. 2024 May 8;21(1):107. doi:10.1186/s12985-024-02379-x.
(6)Ruofei Feng(通訊作者).Mammalian reovirus µ1protein attenuates RIG-I and MDA5-mediated signaling transduction by blockingIRF3 phosphorylation and nuclear translocation. Mol Immunol. 2024Jun;170:131-143. doi: 10.1016/j.molimm.2024.04.010.
(7)Ruofei Feng(通訊作者).New perspective ofsmall-molecule antiviral drugs development for RNA viruses. Virology. 2024Jun;594:110042. doi: 10.1016/j.virol.2024.110042.
(8)Ruofei Feng(通訊作者).Histone H1.2 InhibitedEMCV Replication through Enhancing MDA5-Mediated IFN-β Signaling Pathway.Viruses. 2024 Jan 24;16(2):174. doi: 10.3390/v16020174.
(9)Ruofei Feng(通訊作者). Construction, expressionand assemble of EMCV VLPs and their potency evaluation. Virology. 2023 Jul;584:1-8.doi: 10.1016/j.virol.2023.04.011.
(10)Ruofei Feng(通訊作者). IFITM2 Presents AntiviralResponse through Enhancing Type I IFN Signaling Pathway. Viruses. 2023 Mar28;15(4):866. doi: 10.3390/v15040866.
(11)Ruofei Feng(通訊作者). HSP27 Attenuates cGAS-MediatedIFN-β Signaling through Ubiquitination of cGAS and Promotes PRV Infection.Viruses. 2022 Aug 23;14(9):1851. doi: 10.3390/v14091851.
(12)Ruofei Feng(通訊作者). DDX56 inhibits PRVreplication through regulation of IFN-β signaling pathway by targeting cGAS.Front Microbiol. 2022 Aug 10;13:932842. doi: 10.3389/fmicb.2022.932842.
(13)Ruofei Feng(通訊作者). Pseudorabies Virus ICP0Abolishes Tumor NecrosisFactor Alpha-Induced NF-κB Activation by Degrading P65.Viruses. 2022;14(5):954. Doi:10.3390/v14050954.
(14)Ruofei Feng(通訊作者). DDX56 antagonizes IFN-βproduction to enhance EMCVreplication by inhibiting IRF3 nucleartranslocation[J].Vet Microbiol. 2021 Dec13;264:109304. Doi:10.1016/j.vetmic.2021.109304.
(15)Ruofei Feng(通訊作者). HSP27 ProteinDampensEncephalomyocarditis Virus Replication by StabilizingMelanomaDifferentiation-Associated Gene 5. Front Microbiol. 2021 Nov26;12:788870. Doi:10.3389/fmicb.2021.788870.
(16)Ruofei Feng(通訊作者). Pseudorabies Virus US3Protein Inhibits IFN-β Productionby Interacting With IRF3 to Block ItsActivation[J].Front Microbiol. 2021 Oct22;12:761282. Doi:10.3389/fmicb.2021.761282.
(17)Ruofei Feng(通訊作者). Host protein, HSP90β,antagonizes IFN-β signalingpathway and facilitates the proliferation ofencephalomyocarditis virus invitro[J].Virus Res. 2021 Nov;305:198547. Doi:10.1016/j.virusres.2021.198547.
(18)Ruofei Feng(通訊作者).Encephalomyocarditis virusabrogates the IFN-βsignaling pathway via its structural protein VP2[J].Journalof Virology,2020.12. Doi: 10.1128/JVI.01590-20.
(19)Ruofei Feng(通訊作者). TransmembraneProtein 39APromotes the Replication of Encephalomyocarditis Virus via AutophagyPathway[J].Front. Microbiol., 2019;10:2680. Doi: 10.3389/fmicb.2019.02680.
(20)Ruofei Feng(通訊作者). Host antiviral proteinIFITM2 restrictspseudorabies virus replication[J]. Virus Res., 2020; 287:198105. Doi:10.1016/j.virusres.2020.198105.
(21)RuofeiFeng(通訊作者). Construction,expression,and characterization of a single-chain variable fragment (ScFv)antibodytargeting to the encephalomyocarditis virus. J Med Virol. 2018 Feb 24.Doi: 10.1002/jmv.25065.
(22)RuofeiFeng(通訊作者).Transcriptional profilingofhost cell responses to encephalomyocarditis virus (EMCV). Virol J. 2017 Mar4;14(1):45. Doi: 10.1186/s12985-017-0718-4.
(23)RuofeiFeng(第一作者). National serosurvey ofencephalomyocarditisvirus in healthy people and pigs in China. Archives ofVirology. 2015 Dec;160(12):2957-64.Doi: 10.1007/s00705-015-2591-z
(24)RuofeiFeng(第一作者).Isolation, molecularandphylogenetic analysis of encephalomyocarditis virus strain GS01 in China.Infect Genet Evol. 30(2015):19-26.Doi:10.1016/j.meegid.2014.12.004
(25)RuofeiFeng(第一作者).Infection dynamicsofhepatitis E virus in naturally infected pigs in a Chinesefarrow-to-finishfarm. Infect Genet Evol. 2011,11:1727-1731.Doi:10.1016/j.meegid.2011.07.009
科研獲獎
2010年獲得蘭州市科技進步一等獎
2012年獲得蘭州市科技進步一等獎
2012年獲得甘肅省科技進步二等獎
2013年獲得蘭州市科技進步三等獎
2018年獲得華夏醫學科技獎二等獎
2019年獲得國家民委教學成果二等獎
2020年獲得甘肅省科技進步二等獎
所獲榮譽
2018年入選國家民委中青年英才計畫,2020年獲得甘肅省青年教師成才獎,2021年獲得甘肅省優秀碩士學位論文指導教師稱號。
社會任職
兼任中國細胞生物學學會資深會員、甘肅省免疫學會理事、甘肅省生物工程學會理事、甘肅省免疫學會感染免疫與防治專業委員會副主任委員、甘肅省動物衛生標準化技術委員會委員、甘肅省臨夏縣動物疫病防控專家。